Knowing that REG3γ is involved in shaping the gut microbiota composition [29], we speculated that late-stage glioma could be associated with a shift in bacterial metabolites, which are important mediators allowing the microbiota to modulate host physiology, including the brain. This evidence concerns the gene REG3G and central nervous system cancer.